Breast Milk News and Research RSS Feed - Breast Milk News and Research

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid. [More]
Academy of Nutrition and Dietetics highlights positive effects of human milk on infants, maternal health

Academy of Nutrition and Dietetics highlights positive effects of human milk on infants, maternal health

Human milk provides the best nutrition for most babies and breastfeeding provides the best nutrition for infants and very young children, according to an updated position paper from the Academy of Nutrition and Dietetics. [More]
Two persistent organic environmental pollutants affect infant growth

Two persistent organic environmental pollutants affect infant growth

Even though the levels of two environmental pollutants have declined over the last 20 years, they may still have adverse effects on children's development, according to a new study by the Norwegian Institute of Public Health. This is the largest study of environmental pollutants and infant growth to date. [More]
Common flame retardants linked to obesity, say UH researchers

Common flame retardants linked to obesity, say UH researchers

Could your electronics be making you fat? According to University of Houston researchers, a common flame retardant used to keep electronics from overheating may be to blame. [More]

Formula-fed infants have higher arsenic levels than breast-fed infants

In the first U.S. study of urinary arsenic in babies, Dartmouth College researchers found that formula-fed infants had higher arsenic levels than breast-fed infants, and that breast milk itself contained very low arsenic concentrations. [More]
New research finds that synthetic flame retardants can cause metabolic and liver problems

New research finds that synthetic flame retardants can cause metabolic and liver problems

Chemicals used as synthetic flame retardants that are found in common household items such as couches, carpet padding, and electronics have been found to cause metabolic and liver problems that can lead to insulin resistance, which is a major cause of obesity, according to new research from the University of New Hampshire. [More]
Study: Infant gut microbiota associated with healthy weight gain

Study: Infant gut microbiota associated with healthy weight gain

Researchers in Singapore and UK as part of the EpiGen consortium worked together with scientists at the Nestlé Research Center, Switzerland, on a new study on the bacterial makeup of the gut (gut microbiota) of infants in Singapore. Their study reveals that the rate of bacterial colonisation of the gut is influenced by external factors such as the method of delivery and duration of gestation. [More]
Maternal exposure to flame-retardants may contribute to preterm births

Maternal exposure to flame-retardants may contribute to preterm births

Researchers at The University of Texas Medical Branch have determined that maternal exposure to high levels of flame-retardants may be a contributing factor in preterm births. [More]
Loyola University Medical Center earns Baby-Friendly designation

Loyola University Medical Center earns Baby-Friendly designation

Loyola University Medical Center has earned the coveted Baby-Friendly designation. This verifies that the hospital has implemented the ten steps to help new mothers successfully breastfeed. [More]
Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV. [More]
Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis. [More]
Cell-associated HIV transmission contributes to HIV epidemic

Cell-associated HIV transmission contributes to HIV epidemic

Dr. Deborah Anderson from Boston University School of Medicine (BUSM) and her colleagues are challenging dogma about the transmission of the human immunodeficiency virus type 1 (HIV-1). [More]
FDA approves AbbVie's VIEKIRA PAK for treatment of patients with GT1 HCV infection

FDA approves AbbVie's VIEKIRA PAK for treatment of patients with GT1 HCV infection

The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis. [More]
Toddlers more exposed to brominated flame retardants than their mothers

Toddlers more exposed to brominated flame retardants than their mothers

Toddlers are more exposed to brominated flame retardants (BFRs) at home than their mothers, shows a new doctoral thesis from Stockholm University. [More]
Orexo announces positive results from ISTART/006 study

Orexo announces positive results from ISTART/006 study

Orexo US, Inc. announced results from the ISTART/006 study, being presented today at the 25th Annual Meeting and Symposium of the American Academy of Addiction Psychiatry in Aventura, Florida, USA. [More]
Researchers assess efficiency and safety of breast milk stimulant

Researchers assess efficiency and safety of breast milk stimulant

Most women can make all the milk their baby needs, but some mothers turn to medications to help increase their supply. While some specialists encourage the off-label use of domperidone to stimulate breast milk production, some studies have suggested it may be related to negative side effects, including irregular heartbeat and sudden cardiac death. [More]
Increasing length of breastfeeding could save over £40 million annually for NHS

Increasing length of breastfeeding could save over £40 million annually for NHS

The NHS could save more than £40 million a year by increasing the length of time that mothers breastfeed, according to research carried out at Brunel University London. [More]
New study details weight loss patterns of breastfed newborns

New study details weight loss patterns of breastfed newborns

Using weights obtained from over 100,000 Northern California babies, a new study is the first to detail the weight loss patterns of exclusively breastfed newborns. The results show that some breastfed babies lose weight faster and for a longer period than was previously recognized. [More]
Common antimicrobial in household items causes liver fibrosis, cancer in mice

Common antimicrobial in household items causes liver fibrosis, cancer in mice

Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical. [More]
New NIH-funded study aims to find novel way to treat iron deficiency anemia in children

New NIH-funded study aims to find novel way to treat iron deficiency anemia in children

Penn State College of Medicine and University of Wisconsin have been awarded a five-year, $2.5 million grant from the National Institutes of Health to fund the study of a novel way to treat iron deficiency anemia in children. Iron deficiency is the most common nutritional deficiency and the leading cause of anemia in the United States. [More]
Advertisement
Advertisement